Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Falzon M."'
Autor:
Frankell AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Dietzen M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Ward S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Huebner A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Bunkum A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Grigoriadis K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Liu WK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Thol K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bailey C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bentham R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK., Le Quesne J; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Pathology Department, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK., Biswas D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Puttick C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Lee C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Division of Medicine, University College London, London, UK., Prymas P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Toncheva A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Smith J; Scientific Computing, The Francis Crick Institute, London, UK., Xing W; Scientific Computing, The Francis Crick Institute, London, UK., Nicod J; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Price G; Department of Medical Oncology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK.; University of Aberdeen, Aberdeen, UK., Kerr KM; University of Aberdeen, Aberdeen, UK.; Department of Pathology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK., Naidu B; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Middleton G; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Blyth KG; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Queen Elizabeth University Hospital, Glasgow, UK., Fennell DA; University of Leicester, Leicester, UK.; University Hospitals of Leicester NHS Trust, Leicester, UK., Forster MD; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Lee SM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Falzon M; Department of Cellular Pathology, University College London Hospitals, London, UK., Hewish M; Royal Surrey Hospital, Royal Surrey Hospitals NHS Foundation Trust, Guilford, UK.; University of Surrey, Guilford, UK., Shackcloth MJ; Liverpool Heart and Chest Hospital, Liverpool, UK., Lim E; Academic Division of Thoracic Surgery, Imperial College London, London, UK.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK., Benafif S; Department of Oncology, University College London Hospitals, London, UK., Russell P; Princess Alexandra Hospital, The Princess Alexandra Hospital NHS Trust, Harlow, UK., Boleti E; Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK., Krebs MG; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Lester JF; Singleton Hospital, Swansea Bay University Health Board, Swansea, UK., Papadatos-Pastos D; Department of Oncology, University College London Hospitals, London, UK., Ahmad T; Department of Oncology, University College London Hospitals, London, UK., Thakrar RM; Department of Thoracic Medicine, University College London Hospitals, London, UK.; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Lawrence D; Department of Thoracic Surgery, University College London Hospital NHS Trust, London, UK., Navani N; Department of Thoracic Medicine, University College London Hospitals, London, UK.; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK., Blackhall FH; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Summers Y; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Cave J; Department of Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Marafioti T; Department of Cellular Pathology, University College London Hospitals, London, UK., Herrero J; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Peggs KS; Department of Haematology, University College London Hospitals, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Schwarz RF; Institute for Computational Cancer Biology, Center for Integrated Oncology (CIO), Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Berlin Institute for the Foundations of Learning and Data (BIFOLD), Berlin, Germany., Van Loo P; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Miedema DM; LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark., Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hackshaw A; Cancer Research UK and UCL Cancer Trials Centre, London, UK., Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. m.jamal-hanjani@ucl.ac.uk., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.
Publikováno v:
Nature [Nature] 2024 Jul; Vol. 631 (8022), pp. E15.
Autor:
Spain L; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Department of Medical Oncology, Peter MacCallum Cancer -Centre, Melbourne, Australia., Coulton A; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Tumour Immunogenomics and Immunosurveillance (TIGI) Lab, UCL Cancer Institute, London, United Kingdom., Lobon I; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Schnidrig D; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Shepherd STC; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Shum B; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Byrne F; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Goicoechea M; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Piperni E; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Au L; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Department of Medical Oncology, Peter MacCallum Cancer -Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Edmonds K; The Royal Marsden Hospital, London, United Kingdom., Carlyle E; The Royal Marsden Hospital, London, United Kingdom., Hunter N; The Royal Marsden Hospital, London, United Kingdom., Renn A; The Royal Marsden Hospital, London, United Kingdom., Messiou C; The Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, Kensington and Chelsea, United Kingdom., Hughes P; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Nobbs J; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Foijer F; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., van den Bos H; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Wardenaar R; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Spierings DCJ; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Spencer C; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Schmitt AM; The Royal Marsden Hospital, London, United Kingdom., Tippu Z; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Lingard K; The Royal Marsden Hospital, London, United Kingdom., Grostate L; The Royal Marsden Hospital, London, United Kingdom., Peat K; The Royal Marsden Hospital, London, United Kingdom., Kelly K; The Royal Marsden Hospital, London, United Kingdom., Sarker S; The Royal Marsden Hospital, London, United Kingdom., Vaughan S; The Royal Marsden Hospital, London, United Kingdom., Mangwende M; The Royal Marsden Hospital, London, United Kingdom., Terry L; The Royal Marsden Hospital, London, United Kingdom., Kelly D; The Royal Marsden Hospital, London, United Kingdom., Biano J; The Royal Marsden Hospital, London, United Kingdom., Murra A; The Royal Marsden Hospital, London, United Kingdom., Korteweg J; The Royal Marsden Hospital, London, United Kingdom., Lewis C; The Royal Marsden Hospital, London, United Kingdom., O'Flaherty M; The Royal Marsden Hospital, London, United Kingdom., Cattin AL; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Emmerich M; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; St. John's Institute of Dermatology, Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom., Gerard CL; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Precision Oncology Center, Oncology Department, Lausanne University Hospital, Lausanne, Switzerland., Pallikonda HA; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom., Lynch J; The Royal Marsden Hospital, London, United Kingdom., Mason R; Gold Coast University Hospital, Queensland, Australia., Rogiers A; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom., Xu H; The Francis Crick Institute, London, United Kingdom., Huebner A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom., McGranahan N; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom., Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom., Murai J; Tumour Immunogenomics and Immunosurveillance (TIGI) Lab, UCL Cancer Institute, London, United Kingdom.; Drug Discovery Technology Laboratories, Ono Pharmaceutical Co., Ltd. Osaka, Japan., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom., Borg E; University College London Hospital, London, United Kingdom., Mitchison M; University College London Hospital, London, United Kingdom., Moore DA; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Falzon M; University College London Hospital, London, United Kingdom., Proctor I; University College London Hospital, London, United Kingdom., Stamp GWH; The Francis Crick Institute, London, United Kingdom., Nye EL; The Francis Crick Institute, London, United Kingdom., Young K; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Furness AJS; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.; The Institute of Cancer Research, Kensington and Chelsea, United Kingdom., Pickering L; The Royal Marsden Hospital, London, United Kingdom., Stewart R; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Mahadeva U; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Green A; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Larkin J; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Litchfield K; Tumour Immunogenomics and Immunosurveillance (TIGI) Lab, UCL Cancer Institute, London, United Kingdom., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, United Kingdom.; Department of Medical Oncology, University College London Hospitals, London, United Kingdom., Turajlic S; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Publikováno v:
Cancer discovery [Cancer Discov] 2023 Jun 02; Vol. 13 (6), pp. 1364-1385.
Autor:
Al Bakir M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Grigoriadis K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Ward S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Laycock J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Johnson D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Razaq M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Akther M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Prymas P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Toncheva A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Dietzen M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bunkum A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Lim EL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hiley CT; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Nye E; Experimental Histopathology, The Francis Crick Institute, London, UK., Stone RK; Experimental Histopathology, The Francis Crick Institute, London, UK., Fennell DA; University of Leicester, Leicester, UK.; University Hospitals of Leicester NHS Trust, Leicester, UK., Price G; Department of Medical Oncology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK.; University of Aberdeen, Aberdeen, UK., Kerr KM; University of Aberdeen, Aberdeen, UK.; Department of Pathology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK., Naidu B; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK., Middleton G; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Summers Y; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Lindsay CR; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Blackhall FH; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Cave J; Department of Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Blyth KG; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.; Queen Elizabeth University Hospital, Glasgow, UK., Nair A; Department of Radiology, University College London Hospitals, London, UK.; UCL Respiratory, Department of Medicine, University College London, London, UK., Ahmed A; Department of Radiology, University College London Hospitals, London, UK., Taylor MN; Department of Radiology, University College London Hospitals, London, UK., Procter AJ; Department of Radiology, University College London Hospitals, London, UK., Falzon M; Department of Cellular Pathology, University College London Hospitals, London, UK., Lawrence D; Department of Thoracic Surgery, University College London Hospital NHS Trust, London, UK., Navani N; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.; Department of Thoracic Medicine, University College London Hospitals, London, UK., Thakrar RM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.; Department of Thoracic Medicine, University College London Hospitals, London, UK., Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Papadatos-Pastos D; Department of Oncology, University College London Hospitals, London, UK., Forster MD; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Lee SM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Ahmad T; Department of Oncology, University College London Hospitals, London, UK., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Peggs KS; Department of Haematology, University College London Hospitals, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK., Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, London, UK., Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark., Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. m.jamal-hanjani@ucl.ac.uk., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Charles.Swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. Charles.Swanton@crick.ac.uk.
Publikováno v:
Nature [Nature] 2023 Apr; Vol. 616 (7957), pp. 534-542. Date of Electronic Publication: 2023 Apr 12.
Autor:
Frankell AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Dietzen M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Ward S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Huebner A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Bunkum A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Grigoriadis K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Liu WK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Thol K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bailey C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bentham R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK., Le Quesne J; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Pathology Department, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK., Biswas D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Puttick C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Lee C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Division of Medicine, University College London, London, UK., Prymas P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Toncheva A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Smith J; Scientific Computing, The Francis Crick Institute, London, UK., Xing W; Scientific Computing, The Francis Crick Institute, London, UK., Nicod J; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Price G; Department of Medical Oncology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK.; University of Aberdeen, Aberdeen, UK., Kerr KM; University of Aberdeen, Aberdeen, UK.; Department of Pathology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK., Naidu B; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Middleton G; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Blyth KG; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Queen Elizabeth University Hospital, Glasgow, UK., Fennell DA; University of Leicester, Leicester, UK.; University Hospitals of Leicester NHS Trust, Leicester, UK., Forster MD; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Lee SM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Falzon M; Department of Cellular Pathology, University College London Hospitals, London, UK., Hewish M; Royal Surrey Hospital, Royal Surrey Hospitals NHS Foundation Trust, Guilford, UK.; University of Surrey, Guilford, UK., Shackcloth MJ; Liverpool Heart and Chest Hospital, Liverpool, UK., Lim E; Academic Division of Thoracic Surgery, Imperial College London, London, UK.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK., Benafif S; Department of Oncology, University College London Hospitals, London, UK., Russell P; Princess Alexandra Hospital, The Princess Alexandra Hospital NHS Trust, Harlow, UK., Boleti E; Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK., Krebs MG; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Lester JF; Singleton Hospital, Swansea Bay University Health Board, Swansea, UK., Papadatos-Pastos D; Department of Oncology, University College London Hospitals, London, UK., Ahmad T; Department of Oncology, University College London Hospitals, London, UK., Thakrar RM; Department of Thoracic Medicine, University College London Hospitals, London, UK.; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Lawrence D; Department of Thoracic Surgery, University College London Hospital NHS Trust, London, UK., Navani N; Department of Thoracic Medicine, University College London Hospitals, London, UK.; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK., Blackhall FH; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Summers Y; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Cave J; Department of Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Marafioti T; Department of Cellular Pathology, University College London Hospitals, London, UK., Herrero J; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Peggs KS; Department of Haematology, University College London Hospitals, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Schwarz RF; Institute for Computational Cancer Biology, Center for Integrated Oncology (CIO), Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Berlin Institute for the Foundations of Learning and Data (BIFOLD), Berlin, Germany., Van Loo P; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Miedema DM; LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark., Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hackshaw A; Cancer Research UK and UCL Cancer Trials Centre, London, UK., Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. m.jamal-hanjani@ucl.ac.uk., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.
Publikováno v:
Nature [Nature] 2023 Apr; Vol. 616 (7957), pp. 525-533. Date of Electronic Publication: 2023 Apr 12.
Autor:
Au L; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Hatipoglu E; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London WC1E 6DD, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK., Robert de Massy M; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London WC1E 6DD, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK., Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Beattie G; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London WC1E 6DD, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Schnidrig D; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Thompson R; Retroviral Immunology, The Francis Crick Institute, London NW1 1AT, UK., Byrne F; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Horswell S; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London NW1 1AT, UK., Fotiadis N; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research and Royal Marsden Hospital, London SW3 6JJ, UK., Hazell S; Department of Pathology, the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Nicol D; Department of Urology, the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Shepherd STC; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Fendler A; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Mason R; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Del Rosario L; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Edmonds K; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Lingard K; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Sarker S; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Mangwende M; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Carlyle E; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Attig J; Retroviral Immunology, The Francis Crick Institute, London NW1 1AT, UK., Joshi K; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London WC1E 6DD, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK., Uddin I; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London WC1E 6DD, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK; Division of Infection and Immunity, University College London, London WC1E 6BT, UK., Becker PD; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London WC1E 6DD, UK., Sunderland MW; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London WC1E 6DD, UK., Akarca A; Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK., Puccio I; Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK., Yang WW; Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK., Lund T; Translational Immune Oncology Lab, Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton SM2 5PT, UK., Dhillon K; Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK., Vasquez MD; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London WC1E 6DD, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK., Ghorani E; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London WC1E 6DD, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK., Xu H; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Spencer C; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK., López JI; Department of Pathology, Cruces University Hospital, Biocruces-Bizkaia Institute, 48903 Barakaldo, Bizkaia, Spain., Green A; Department of Cellular Pathology, Guy's & St Thomas' NHS Foundation Trust, St Thomas' Hospital, London SE1 7EH, UK., Mahadeva U; Department of Cellular Pathology, Guy's & St Thomas' NHS Foundation Trust, St Thomas' Hospital, London SE1 7EH, UK., Borg E; Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK., Mitchison M; Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK; Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK., Proctor I; Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK., Falzon M; Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK., Pickering L; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Furness AJS; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Reading JL; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London WC1E 6DD, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK., Salgado R; Division of Research, Peter MacCallum Cancer Centre, Melbourne VIC 300, Australia; Department of Pathology, GZA-ZNA Hospitals, Wilrijk, Antwerp, Belgium., Marafioti T; Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK; Cancer Metastasis Laboratory, University College London Cancer Institute, London WC1E 6DD, UK; Department of Medical Oncology, University College London Hospitals, London NW1 2BU, UK., Kassiotis G; Retroviral Immunology, The Francis Crick Institute, London NW1 1AT, UK., Chain B; Division of Infection and Immunity, University College London, London WC1E 6BT, UK; University College London Cancer Institute, London WC1E 6DD, UK., Larkin J; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Department of Medical Oncology, University College London Hospitals, London NW1 2BU, UK; University College London Cancer Institute, London WC1E 6DD, UK., Quezada SA; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London WC1E 6DD, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK. Electronic address: s.quezada@ucl.ac.uk., Turajlic S; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK. Electronic address: samra.turajlic@crick.ac.uk.
Publikováno v:
Cancer cell [Cancer Cell] 2021 Nov 08; Vol. 39 (11), pp. 1497-1518.e11. Date of Electronic Publication: 2021 Oct 28.
Autor:
Ishii Y; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Kolluri KK; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Pennycuick A; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Zhang X; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Nigro E; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom; Department of Environmental, Biological, and Pharmaceutical Sciences and Technologies, University of Campania Luigi Vanvitelli, Caserta, Italy., Alrifai D; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Borg E; Department of Histopathology, University College London Hospital, London, United Kingdom., Falzon M; Department of Histopathology, University College London Hospital, London, United Kingdom., Shah K; Center for Stem Cell Therapeutics and Imaging, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Kumar N; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom. Electronic address: neelam.kumar@alumni.ucl.ac.uk., Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom. Electronic address: s.janes@ucl.ac.uk.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2021 Nov; Vol. 297 (5), pp. 101223. Date of Electronic Publication: 2021 Sep 29.
Autor:
Adegun OK; Department of Cellular Pathology, University College London Hospitals NHS Foundation Trust, London, UK., Proctor I; Department of Cellular Pathology, University College London Hospitals NHS Foundation Trust, London, UK., Falzon M; Department of Cellular Pathology, University College London Hospitals NHS Foundation Trust, London, UK., Pomplun S; Department of Cellular Pathology, University College London Hospitals NHS Foundation Trust, London, UK.
Publikováno v:
Diagnostic cytopathology [Diagn Cytopathol] 2021 Aug; Vol. 49 (8), pp. E325-E328. Date of Electronic Publication: 2021 Apr 01.
Autor:
Vaidya JS; Division of Surgery and Interventional Science, University College London, London, UK. jayantvaidya@gmail.com., Bulsara M; Department of Biostatistics, University of Notre Dame, Fremantle, WA, Australia., Baum M; Division of Surgery and Interventional Science, University College London, London, UK., Wenz F; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Massarut S; Department of Surgery, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Pigorsch S; Department of Radiation Oncology, Red Cross Hospital, Technical University of Munich, Munich, Germany., Alvarado M; Department of Surgery, University of California, San Francisco, CA, USA., Douek M; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Saunders C; School of Surgery, University of Western Australia, Perth, WA, Australia., Flyger H; Department of Breast Surgery, University of Copenhagen, Copenhagen, Denmark., Eiermann W; Department of Gynecology and Obstetrics, Red Cross Hospital, Technical University of Munich, Munich, Germany., Brew-Graves C; Division of Surgery and Interventional Science, University College London, London, UK., Williams NR; Division of Surgery and Interventional Science, University College London, London, UK., Potyka I; Division of Surgery and Interventional Science, University College London, London, UK., Roberts N; Division of Surgery and Interventional Science, University College London, London, UK., Bernstein M; Patient advocate and writer, London, UK., Brown D; Department of Surgery, Ninewells Hospital, Dundee, UK., Sperk E; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Laws S; Department of Surgery, Royal Hampshire County Hospital, Winchester, UK., Sütterlin M; Department of Gynecology and Obstetrics, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Berlin, Germany., Corica T; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia., Lundgren S; Department of Oncology, St Olav's University Hospital, & Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Holmes D; John Wayne Cancer Institute & Helen Rey Breast Cancer Foundation, University of Southern California, Los Angeles, CA, USA., Vinante L; Department of Radiation Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Bozza F; Department of Surgery, Instituto Oncologico Veneto (IVO) IRCCS, Padoa, Italy., Pazos M; Department of Radiation Oncology, University Hospital, Ludwig Maximilians Universitat, Munich, Germany., Blanc-Onfroy ML; Oncologie radiothérapeute, Institut de Cancérologie de l'Ouest, Nantes, France., Gruber G; Brust Zentrum Seefeld, Zurich, Switzerland., Polkowski W; Department of Surgical Oncology, Medical University of Lublin, Lublin, Poland., Dedes KJ; Breast Center, Universitätsspital Zürich, Zurich, Switzerland., Niewald M; Saarland University Medical Center, Homburg, Germany., Blohmer J; Sankt Gertrauden-Krankenhaus, and The Charité-Universitätsmedizin Berlin, Berlin, Germany., McReady D; Princess Margaret Cancer Centre, Toronto, Canada., Hoefer R; Sentara Surgery Specialists, Hampton, VA, USA., Kelemen P; Ashikari Breast Center, New York Medical College, New York, NY, USA., Petralia G; Department of Surgery, University College London Hospitals, London, UK., Falzon M; Department of Pathology University College London Hospitals, London, UK., Joseph D; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia., Tobias JS; Department of Clinical Oncology, University College London Hospitals, London, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Aug; Vol. 125 (3), pp. 380-389. Date of Electronic Publication: 2021 May 25.
Autor:
Pennycuick A; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Teixeira VH; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., AbdulJabbar K; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Raza SEA; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Department of Computer Science, University of Warwick, Coventry, United Kingdom., Lund T; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, United Kingdom.; Research Department of Haematology, University College London Cancer Institute, University College London, London, United Kingdom.; UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom., Akarca AU; Department of Cellular Pathology, University College London Hospital, London, United Kingdom., Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Kalinke L; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Chandrasekharan DP; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Pipinikas CP; University College London Cancer Institute, London, United Kingdom., Lee-Six H; The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom., Hynds RE; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; University College London Cancer Institute, London, United Kingdom., Gowers KHC; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Henry JY; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, United Kingdom., Millar FR; Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom., Hagos YB; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Denais C; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Falzon M; Department of Cellular Pathology, University College London Hospital, London, United Kingdom., Moore DA; UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom.; Department of Cellular Pathology, University College London Hospital, London, United Kingdom., Antoniou S; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Durrenberger PF; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Furness AJ; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Carroll B; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Marceaux C; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Asselin-Labat ML; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Knight Cancer Institute, Cancer Early Detection and Advanced Research (CEDAR) Center, Oregon Health & Science University, Portland, Oregon., Larson W; Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon., Betts C; Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon., Coussens LM; Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon., Thakrar RM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., George J; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom., Swanton C; UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; University College London Cancer Institute, London, United Kingdom., Thirlwell C; University College London Cancer Institute, London, United Kingdom.; University of Exeter College of Medicine and Health, Exeter, United Kingdom., Campbell PJ; The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom., Marafioti T; Department of Cellular Pathology, University College London Hospital, London, United Kingdom., Yuan Y; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Quezada SA; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, United Kingdom.; Research Department of Haematology, University College London Cancer Institute, University College London, London, United Kingdom.; UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom., McGranahan N; University College London Cancer Institute, London, United Kingdom. s.janes@ucl.ac.uk nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, United Kingdom., Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom. s.janes@ucl.ac.uk nicholas.mcgranahan.10@ucl.ac.uk.; UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom.
Publikováno v:
Cancer discovery [Cancer Discov] 2020 Oct; Vol. 10 (10), pp. 1489-1499. Date of Electronic Publication: 2020 Jul 20.
Autor:
Vaidya JS; Division of Surgery and Interventional Science, University College London, London, United Kingdom., Bulsara M; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Biostatistics, University of Notre Dame, Fremantle, West Australia, Australia., Saunders C; University of Western Australia School of Surgery, West Australia, Australia., Flyger H; Department of Breast Surgery, University of Copenhagen, Copenhagen, Denmark., Tobias JS; Department of Clinical Oncology, University College London Hospitals, London, United Kingdom., Corica T; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Perth, West Australia, Australia., Massarut S; Department of Surgery, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Wenz F; University Medical Center Mannheim, Department of Radiation Oncology, Medical Faculty Mannheim, Heidelberg University, Germany., Pigorsch S; Red Cross Hospital, Department of Gynecology and Obstetrics, Technical University of Munich, Munich, Germany., Alvarado M; Department of Surgery, University of California, San Francisco., Douek M; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom., Eiermann W; Red Cross Hospital, Department of Gynecology and Obstetrics, Technical University of Munich, Munich, Germany., Brew-Graves C; Division of Surgery and Interventional Science, University College London, London, United Kingdom., Williams N; Division of Surgery and Interventional Science, University College London, London, United Kingdom., Potyka I; Division of Surgery and Interventional Science, University College London, London, United Kingdom., Roberts N; Division of Surgery and Interventional Science, University College London, London, United Kingdom., Bernstein M; Patient Advocate and Writer, London, United Kingdom., Brown D; Department of Surgery, Ninewells Hospital, Dundee, United Kingdom., Sperk E; University Medical Center Mannheim, Department of Radiation Oncology, Medical Faculty Mannheim, Heidelberg University, Germany., Laws S; Department of Surgery, Royal Hampshire County Hospital, Winchester, United Kingdom., Sütterlin M; University Medical Center Mannheim, Department of Gynecology and Obstetrics, Medical Faculty Mannheim, Heidelberg University, Germany., Lundgren S; Department of Oncology, St Olav's University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Holmes D; Helen Rey Breast Cancer Foundation, John Wayne Cancer Institute, University of Southern California, Los Angeles., Vinante L; Department of Radiation Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Bozza F; Instituto Oncologico Veneto, Padoa, Italy., Pazos M; University Hospital, Department of Radiation Oncology, Ludwig Maximilians Universitat, Munich, Germany., Le Blanc-Onfroy M; Oncologue radiothérapeute, Institut de Cancérologie de l'Ouest, Nantes, France., Gruber G; Brust Zentrum Seefeld, Zurich, Zurich, Switzerland., Polkowski W; Department of Surgical Oncology, Medical University of Lublin, Lublin, Poland., Dedes KJ; Breast Center, Universitätsspital Zürich, Zurich, Switzerland., Niewald M; Saarland University Medical Center, Homberg, Germany., Blohmer J; Sankt Gertrauden-Krankenhaus, and The Charité - Universitätsmedizin Berlin, Berlin, Germany., McCready D; Princess Margaret Cancer Centre Toronto, Toronto, Ontario, Canada., Hoefer R; Sentara Surgery Specialists, Hampton, Virginia., Kelemen P; Ashikari Breast Center, New York Medical College, New York, New York., Petralia G; Department of Surgery, University College London Hospitals, London, United Kingdom., Falzon M; Department of Pathology, University College London Hospitals, London, United Kingdom., Baum M; Division of Surgery and Interventional Science, University College London, London, United Kingdom., Joseph D; Department of Radiation Oncology, Sir Charles Gairdner Hospital, Perth, West Australia, Australia.
Publikováno v:
JAMA oncology [JAMA Oncol] 2020 Jul 01; Vol. 6 (7), pp. e200249. Date of Electronic Publication: 2020 Jul 09.